抗がん剤誘発遅延性悪心・嘔吐に対する低用量ステロイドの有用性の評価
スポンサーリンク
概要
- 論文の詳細を見る
A prospective comparative study was conducted to assess the efficacy and safety of low-dose steroids for delayed nausea in patients who had received platinum-based chemotherapy. Out of the 46 patients enrolled as our subjects, 21 were given 2 mg of dexamethasone (dexamethasone group) and 23 received no dexamethasone (control group).All patients enrolled were treated with dexamethasone (8 to 20 mg) and an intravenous 5-HT3 receptor antagonist prior to chemotherapy for the prevention of acute emesis. Following chemotherapy, they assessed themselves for nausea and anorexia for 7 days. When these symptoms were noted, dexamethasone was administered to patients in the dexamethasone group at 2 mg for 4 days. As the results of our study, nausea and anorexia were apparently relieved in the dexamethasone group and prolonged nausea and anorexia occurred in the control group. The nausea scores changed from 0.68 to 0.17 and from 0.70 to 0.72, respectively, in the dexamethasone group and control groups, respectively, and the anorexia scale scores from 1.33 to 0.60 and from 1.44 to 1.51, respectively, in the two groups. In the dexamethasone group, the improvement rate for nausea changed from 34.8% to 57.1% and that for anorexia changed from 17.4% to 71.4%, both significantly higher than in the control group. Though one patient in the dexamethasone group experienced mild heartburn, no other adverse events were observed, indicating that 2 mg of dexamethasone was well tolerated. In conclusion, we consider that low-dose steroid therapy in the early stages maybe clinically effective for delayed nausea.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)